Search
Cositecan
go.drugbank.com/drugs/DB05806InvestigationalIt has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.
Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine
go.drugbank.com/drugs/DB10061ApprovedInvestigationalfour drug substances contained in each dose of vaccine. … [A253277] Several serogroups of _N. meningitidis_ - A, B, C, Y, and W-135 - known to cause meningococcal infections have been identified.
Canertinib
go.drugbank.com/drugs/DB05424InvestigationalCanertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. … Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
Categories: Compounds used in a research, industrial, or household settingMagnesium glycinate
go.drugbank.com/drugs/DB11189ApprovedInvestigationalIt is used in the treatment of magnesium deficiency.
S-8510
go.drugbank.com/drugs/DB06504ExperimentalIt was being codeveloped by Shionogi and GlaxoSmithKline.
Medrysone
go.drugbank.com/drugs/DB00253ApprovedMedrysone is a corticosteroid used in ophthalmology.
Synonyms: 11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dioneTolazamide
go.drugbank.com/drugs/DB00839ApprovedA sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide.
Synonyms: N-(p-Toluenesulfonyl)-N'-hexamethyleniminoureaCategories: Drugs Used in DiabetesPropyphenazone
go.drugbank.com/drugs/DB13524InvestigationalPropyphenazone is a non-steroidal anti-inflammatory agent with analgesic effects.
Mixtures: Adolomed 250 mg/300 mg/50 mg Tabletten, DERMAN 300 MG/100 MG/50 MG KAŞE, 1 KAŞEAminobenzoic acid
go.drugbank.com/drugs/DB02362ApprovedWithdrawnIt used to be common in sunscreening agents until found to also be a sensitizer. The potassium salt is used therapeutically in fibrotic skin disorders.
EC-0652
go.drugbank.com/drugs/DB15340ExperimentalEC-0652 is under investigation in clinical trial NCT02202447 (Phase 1 of EC1169 In Patients With Recurrent MCRPC).